Circular Single-Stranded DNA-Based Artificial Nanoviruses Mitigate Colorectal Cancer Development

Jinghao Wang1,2, Pengfei Zhang2, Yonglian Huang2

  • 1Department of Chemistry, University of Science & Technology of China, Hefei, Anhui, 230026, China.

Small Methods
|January 22, 2025
PubMed

Insights

Researchers developed novel circular single-stranded DNA (CssDNA) therapies inspired by plant viruses to target oncogenic microRNAs (oncomiRs) in colorectal cancer (CRC). This approach effectively restores tumor suppressor gene expression, reducing CRC progression in vitro and in vivo.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Colorectal cancer (CRC) presents a significant global health burden, necessitating advanced therapeutic interventions.
  • Oncogenic microRNAs (oncomiRs) are critical drivers in the initiation and progression of CRC, representing key therapeutic targets.

Purpose of the Study:

  • To investigate the therapeutic potential of circular single-stranded DNA (CssDNA) constructs, inspired by plant nanoviruses, for targeting oncomiRs in CRC.
  • To develop and validate CssDNA molecules designed to sequester specific oncomiRs, thereby restoring tumor suppressor gene (TSG) expression and inhibiting CRC.

Main Methods:

  • A multi-omics strategy was employed to identify crucial TSGs and their associated oncomiRs in CRC.
  • Engineered CssDNA molecules were designed, each incorporating multiple binding sites to target specific oncomiRs.
  • In vitro and in vivo experiments were conducted to assess the efficacy of CssDNA transfection in CRC cells and animal models.

Main Results:

  • The developed CssDNA effectively targeted and sequestered specific oncomiRs within CRC cells.
  • Restoration of TSG expression was observed following CssDNA treatment.
  • Significant reduction in CRC development was demonstrated both in vitro and in vivo.

Conclusions:

  • Nanovirus-inspired CssDNA represents a promising therapeutic strategy for modulating miRNA-mediated regulatory networks in colorectal cancer.
  • This study establishes a foundation for novel non-coding DNA-based therapies for CRC and potentially other cancers.

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.0K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.5K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
4.9K